{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-078549","form_type":"8-K","ticker":"ORKA","cik":"0000907654","company_name":"Oruka Therapeutics, Inc.","filed_at":"2024-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.257879+00:00","generated_at":"2026-05-31T05:06:05.726859+00:00","sec_items":["1.01","5.03","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Oruka raises $200M via PIPE; accelerates ORKA-001/002 clinical timelines","bullets":["Gross proceeds of ~$200M from sale of common stock, preferred stock, and pre-funded warrants at $23.00 per common share.","Cash runway extended through 2027; closing expected September 13, 2024.","First-in-human dosing of ORKA-001 (IL-23p19 mAb) now expected Q1 2025; ORKA-002 (IL-17A/F mAb) expected Q3 2025.","Preclinical data show ORKA-001 half-life >30 days in NHPs; data to be presented at EADV September 25-28.","Pro forma shares outstanding expected to be ~55.1 million including all conversions and warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-078549","json":"https://secwatch.observer/filing/0001213900-24-078549.json","markdown":"https://secwatch.observer/filing/0001213900-24-078549.md","text":"https://secwatch.observer/filing/0001213900-24-078549.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/907654/000121390024078549/0001213900-24-078549-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/907654/000121390024078549/ea0214439-8k_oruka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:06:05.726859+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}